← back to database
Rapha Capital Management identifies and actively grows potentially disruptive biotechnology, medical-device, and healthcare companies, spanning early-stage venture investments and selected mid- and later-stage opportunities.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$100 million Rapha Capital BioVentures Fund I
Latest fund vintage
2021
Investing team
Kevin Slawin, MDFounder & Managing Partner
How to reach them
Notable investments
Sources
raphacap.com ↗raphacap.com/about-us ↗raphacap.com/portfolio ↗rcpelsfundvi.raphacapitalpe.com ↗finder.startupnationcentral.org/investor_page/rapha-capital-management ↗cdn.startupgenome.com/sites/62c58b4d00b3f50043b92724/content_entry62c58c4b00b3f50043b92770/62c59d2e61a37b003e2b3386/files/Global_Startup_Ecosystem_Report_GSER_2021.pdf ↗